Show source-provided references
5. Hepatic Fibrosis Is Universal Following Fontan Operation, and Severity is Associated With Time From Surgery: A Liver Biopsy and Hemodynamic Study
10.1161/JAHA.116.004809 ↗8. Noninvasive diagnosis of liver fibrosis in the complex cardiac malformation survivors—A review of the literature
10.11152/mu-2850 ↗11. Reference values of normal liver stiffness in healthy children by two methods: 2D shear wave and transient elastography
10.1038/s41598-020-64320-w ↗12. The assessment of liver fibrosis in children with obesity on two methods: Transient and two dimensional shear wave elastography
10.1038/s41598-019-56358-2 ↗13. Elastography in Chronic Liver Disease: Modalities, Techniques, Limitations, and Future Directions
10.1148/rg.2016160042 ↗15. Shear wave elastography may be sensitive and more precise than transient elastography in predicting significant fibrosis
10.12998/wjcc.v8.i17.3730 ↗17. Noninvasive assessment of liver fibrosis in patients with Fontan circulation using transient elastography and biochemical fibrosis markers
18. Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: Proof of concept and first application in a large population
10.1016/j.jhep.2012.04.025 ↗19. The FibroTest value in discriminating between insiginificant and significant fibrosis in chronic hepatitis C patients. The Romanian experience
22. Validation of non-invasive biomarkers (FibroTest, SteatoTest and NashTest) for prediction of liver injury in patients with morbid obesity
10.1097/MEG.0b013e3283464111 ↗23. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C
10.1053/jhep.2003.50346 ↗24. Development of a simple noninvasive index to predict significant fibrosis patients with HIV/HCV coinfection
10.1002/hep.21178 ↗25. Sonographic assessment of the normal limits and percentile curves of liver, spleen, and kidney dimensions in healthy school-aged children
10.7863/jum.2005.24.10.1359 ↗26. Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: An updated meta-analysis
10.1002/hep.24105 ↗28. A composite noninvasive index correlates with liver fibrosis scores in post-Fontan patients: Preliminary findings
10.1111/chd.12558 ↗29. Increased hepatic stiffness as consequence of high hepatic afterload in the Fontan circulation: A vascular Doppler and elastography study
10.1002/hep.26631 ↗30. Hepatic stiffness in the bidirectional cavopulmonary circulation: The Liver Adult-Pediatric-Congenital-Heart-Disease Dysfunction Study group
10.1016/j.jtcvs.2015.09.079 ↗34. Shear-wave elastography for the estimation of liver fibrosis in chronic liver disease: Determining accuracy and ideal site for measurement
10.1148/radiol.14140839 ↗35. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease
10.1136/gut.2006.111302 ↗36. Transient elastography may identify Fontan patients with unfavorable hemodynamics and advanced hepatic fibrosis
10.1111/chd.12159 ↗39. Late hepatic complications after Fontan operation; non-invasive markers of hepatic fibrosis and risk factors
10.1136/hrt.2010.201772 ↗43. Non-invasive fibrosis seromarkers as a predictor of liver fibrosis in chronic hepatitis C and/or non-alcoholic steatohepatitis
10.1016/j.ajg.2009.03.007 ↗44. Non-invasive Investigations for the Diagnosis of Fontan-Associated Liver Disease in Pediatric and Adult Fontan Patients
10.3389/fcvm.2017.00015 ↗45. Hepatic Inflammation May Influence Liver Stiffness Measurements by Transient Elastography in Children and Young Adults
10.1097/MPG.0000000000001376 ↗46. Novel biomarkers predict liver fibrosis in hepatitis C patients: Alpha 2 macroglobulin, vitamin D binding protein and apolipoprotein AI
10.1186/1423-0127-17-58 ↗47. The impact of liver disease etiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: An international study of 2411 cases
10.1111/j.1365-2036.2011.04861.x ↗